Understanding the Growth of Private Markets

Date:

Share post:


Private markets now shape capital formation, portfolio construction, and financial stability. This report examines private markets’ growth, risks, and implications for investors, policymakers, intermediaries, and the investment profession.

At a Glance

  • Private markets are now central to capital formation, as more companies stay private longer and institutional allocations to private enterprises rise.
  • The growth of private markets is changing capital market structure; that is, they are changing how capital is raised, priced, governed, and deployed throughout the economy.
  • Issuers, asset owners, intermediaries, and policymakers are reinforcing the shift to private markets as companies seek flexible capital, investors seek enhanced returns, managers seek higher-fee products, and governments seek long-term investment funding.
  • Key considerations for success include improved disclosure transparency, valuation standards, investor protection safeguards, and governance oversight.
  • Investment professionals must build the knowledge, skills, and capabilities necessary to strengthen valuation processes, liquidity planning, governance, performance measurement, and systemic risk oversight .

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

What if AI’s biggest impact on music isn’t just what gets made, but what gets wanted?

MBW Views is a series of op-eds from eminent music industry people… with something to say. The...

4 Ways to Lower Your Healthcare Costs in Retirement So They Don’t Upend Your Budget

Healthcare is one of the biggest expenses many retirees face. And unfortunately, it's a cost that tends...

The Biggest Problem in Investing Right Now

Financial product ads are often unconcerned with the truth, or in the words of philosopher Harry Frankfurt, they...

The SEC’s Proposal for Semiannual Reporting

Many large companies support the proposal including business associations, oil & gas, and pharmaceuticals. Eli Lilly, for...